Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

December 6, 2019

Study Completion Date

December 6, 2019

Conditions

Graft Versus Host Disease

Interventions

DRUG

Teduglutide

Treatment of patients with SR-GI-GVHD with teduglutide

Trial Locations (1)

Medical Center University of Freiburg, Freiburg im Breisgau

All Listed Sponsors

lead

University of Freiburg

OTHER

NCT04290429 - Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients | Biotech Hunter | Biotech Hunter